We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
We're providing £1.24m through our Virtual Biotech programme to help test a potential treatment called MTX325 in people with Parkinson's.
Date
We're providing £1.55m through our Virtual Biotech programme to carry out the first clinical trials to see if HER-096 is safe for people with Parkinson's and to start exploring its potential benefits.
Date
Parkinson's UK is funding researchers to develop a potential set of drugs against a new target for people with Parkinson's.
Date
Research co-funded by Parkinson's UK finds a new way to potentially improve diagnosis and monitoring of Parkinson's.
Date
We've supported the principle that everyone in Scotland who needs it should have a legal right to palliative care. However, the new law would need additional funding and to be on the right terms for people with Parkinson's and their families.
Date
We're providing £1.6m through our Virtual Biotech programme to develop a potential new treatment targeting mitochondria to protect brain cells in Parkinson's patients.
Date
A partnership involving Parkinson's UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Date
Parkinson's UK and Everyone Active have been awarded the Sport, Travel and Leisure partnership award winners at the 2024 Third Sector Business Charity Awards.
Date
We're funding Places Leisure's new Move and Shout project, which is offering physical activity classes for people with Parkinson's in Andover, Sheffield, Waltham Abbey, West Bromwich and Wycombe this spring.
Date
Campaigners are calling for the prescription charge exemption list in England to be reviewed following the price rise.